Navigation Links
Ovarian Cancer Vaccine Clinical Trial Begins at Cancer Treatment Centers of America
Date:5/22/2008

Dr. Sybilann Williams, gynecologic oncologist and surgeon at CTCA along with Dr. David Berd, chief medical officer of AVAX, will serve as investigators.

"CTCA offers a powerful combination of traditional and innovative therapies provided by a team of cancer experts who work with each patient individually, to determine the appropriate combination of therapies to fight cancer," Dr. Williams said. "Ovarian cancer is a very complex disease that is often resistant to chemotherapy, radiation and surgery. CTCA will offer our patients the opportunity to be involved in another ground-breaking step in the fight against ovarian cancer."

The American Cancer Society ranks ovarian cancer as the eighth most common cancer among women, and it is the fifth leading cause of cancer-related deaths in women. It is estimated that there will be 21,650 new cases of ovarian cancer in the U.S. in 2008 and 15,520 cancer-related deaths. Ovarian cancer occurs in about one out of every 69 women, according to the Ovarian Cancer National Alliance.

"We are enthusiastic about receiving FDA clearance to start this important clinical trial and with the opportunity it affords us to collaborate with CTCA," stated AVAX's Dr. Berd. "Clearly, better treatments for ovarian cancer are needed and we hope the vaccine will eventually find its place as a relatively non-toxic therapeutic alternative for these patients.

More information about the vaccine trial, ovarian cancer, and ovarian cancer treatment can be found at http://www.cancercenter.com/landing-pages/ovarian-cancer/default.cfm. Patients interested in the clinical trial may contact a CTCA Oncology Information Specialist at 877-98-TRIAL.

About Cancer Treatment Centers of America

Founded in 1988, Cancer Treatment Centers of America (CTCA) is a network of cancer treatment hospitals and community oncology programs in Ill
'/>"/>

SOURCE Cancer Treatment Centers of America
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer
2. Join NPRs David Ewing Duncan, Author Jessica Queller and a Panel of Medical and Legal Experts in a 90-Minute Webcast on Genetic Testing, Genomic Medicine and Breast & Ovarian Cancer
3. BiPar Sciences Expands Phase 2 Clinical Trials of BSI-201, a Novel DNA Repair Inhibitor, in Ovarian Cancer
4. BSI-201 Demonstrates Significant Tumor Growth Inhibition and Increased Survival Rates in Preclinical Ovarian Cancer Studies
5. Vermillions Biomarkers Prove Beneficial in Identifying Women With Ovarian Cancer and Detecting Early-Stage Disease
6. Sunesis Pharmaceuticals Reports Positive Interim Data for SNS-595 Single-Agent Activity in Platinum-Resistant Ovarian Cancer
7. BioNumerik Commences Global Phase III Ovarian Cancer Trial on Novel Anticancer Drug Candidate Known as Karenitecin(R)
8. EntreMed Commences Phase 2 Study With MKC-1 in Ovarian/Endometrial Cancers
9. Northwest Biotherapeutics Conducting Ovarian Cancer Clinical Trial With DCVax(R)-L at University of Pennsylvania
10. Clinical Studies of OvaRex in Advanced Ovarian Cancer Fail to Meet Primary Endpoint
11. Sunesis Pharmaceuticals Reports Preliminary SNS-595 Activity in Ovarian Cancer Clinical Trial at AACR-NCI-EORTC International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... 10, 2014  RESMED INC. (NYSE: RMD ) ... fiscal year ended June 30, 2014 results on Thursday, July ... A press release with ResMed,s results will be issued after ... a webcast to discuss operating results and future outlook. ... p.m. US Pacific Time and the live webcast of the ...
(Date:7/10/2014)... , July 10, 2014  Decision Resources ... surveyed infectious disease (ID) specialists are willing to ... Orbactiv (oritavancin) for use as OPAT, approximately two-thirds ... these agents to their hospital inpatients. However, our ... OPAT patients are initiated on OPAT following hospital ...
(Date:1/15/2014)... -- ChinaMarketResearchReports.com adds "China Orthopedic Instrument Industry Report, 2013-2015" ... (Photo: http://photos.prnewswire.com/prnh/20140115/MN46792 ) Benefiting from aging ... China,s orthopedic instrument industry has seen rapid ... from 3.28 billion yuan in 2006 to 9.85 billion ...
Breaking Medicine Technology:ResMed To Announce Fourth Quarter And Fiscal Year-End 2014 Results 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 2Long-Acting Antibiotics Offering Once-Weekly Dosing Will See Favorable Uptake and Use as Outpatient Parenteral Antimicrobial Therapy (OPAT) 3Orthopedic Instrument Industry in China Markets Forecast to 2015 2Orthopedic Instrument Industry in China Markets Forecast to 2015 3
... DecisionView Inc., a leading provider of software ... sciences companies, today announced the release of StudyOptimizer ... solution for patient enrollment planning, tracking and forecasting. ... site performance and cost projections, StudyOptimizer 4.3 significantly ...
... Mich., July 19, 2011 Terumo Heart, Inc., a ... a patient implanted with the DuraHeart™ Left Ventricular Assist ... the mechanical circulatory support device.  Helga Gieseke, living in ... German Heart Institute Berlin) and is now one of ...
Cached Medicine Technology:DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 2DecisionView StudyOptimizer 4.3™ Enhances Market-Leading Enrollment Optimization Solution With Greater Visibility Into Site Performance and Cost Forecasting 3German Patient Surpasses 5 Years of Support on DuraHeart™ Left Ventricular Assist Device 2German Patient Surpasses 5 Years of Support on DuraHeart™ Left Ventricular Assist Device 3
(Date:7/13/2014)... Carolinas Healthcare System celebrated today the grand ... System - Anson located in Anson County. The $20 ... in Wadesboro. , Located on U.S. Highway 74, the ... facility. Situated on a 10-acre site, the new hospital ... drop-off, helipad, healing garden, and 15 beds. With fewer ...
(Date:7/13/2014)... 2014 Chromatography system is a ... various types of biological samples such as air ... mixture into two phase, namely mobile phase and ... run over the stationary phase, followed by the ... provide the separation of mixture. Chromatography system plays ...
(Date:7/13/2014)... 2014 Micro irrigation systems are mainly ... dispersal as wells as to maintain soil quality. The ... to become a dominant revenue generator for manufacturers in ... reduce resource costs has led to the adoption of ... has further caused massive demand for micro irrigation systems, ...
(Date:7/13/2014)... According to a new market research report "Heterogeneous ... GPU, DSP, connectivity), Technology Node (45nm-5nm), Application (Consumer, ... and Analysis to 2014-2020", published by MarketsandMarkets, the ... expected to reach $61.70 Billion by 2020, growing ... 2020. , Browse 71 market data Tables with ...
(Date:7/13/2014)... 13, 2014 The Pearland, Texas location of ... age from four months to 12 years of age that ... to birthday parties and Summer Camps, is now under new ... of Pearland after spending over six years at The ... Gym Director. , Berry has over ten years of ...
Breaking Medicine News(10 mins):Health News:Carolinas HealthCare System - Anson Hospital Now Open 2Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 2Health News:North America Chromatography Systems Market Is Expected to Reach $6593.4 Million by 2018 - New Report by MicroMarket Monitor 3Health News:Agricultural Micro Irrigation System Market is Expected to Grow at a CAGR of 18.1%, from 2013 to 2018 - New Report by MicroMarket Monitor 2Health News:Agricultural Micro Irrigation System Market is Expected to Grow at a CAGR of 18.1%, from 2013 to 2018 - New Report by MicroMarket Monitor 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 2Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 3Health News:Heterogeneous Mobile Processing & Computing Market Worth $61.70 Billion by 2020 – New Report by MarketsandMarkets 4Health News:The Little Gym of Pearland, TX Now Under New Ownership and Management 2
... Flag Company, Inc.,s new ,Feel Good, Light Lenses are perfect decorating ... trying economical time. , ... (PRWEB) March 3, 2009 ... the nation, the Flag Company, Inc. recently launched ,Feel Good, Light ...
... a series of residential vacuum cleaner reviews conducted in collaboration with ... ... 3, 2009 -- Before spending hundreds of dollars on one of the ... to the Internet to research their choices. , , , , ,In ...
... /PRNewswire/ -- CMPMedica, the global ... Business Media Limited, has signed an agreement with MAIDIS, ... medicine management system for two hospitals in the United ... used in approximately 700 hospitals in France, 120 in ...
... Researchers to Speak on Treatment ModalitiesMOUNTAIN VIEW, Calif., ... the nation,s first and largest providers of kidney ... research, today announced that several of its internationally ... Annual Dialysis Conference in Houston, Texas March 8-10. ...
... the U.S. Government Accountability Office (GAO) Report on the ... Responsible Nutrition (CRN), the leading trade association representing the ... from Steve Mister, president and CEO, CRN: "As ... that this one demonstrates that the industry has come ...
... in mice, appear to overcome a major drawback of vaccinations ... it normally takes for immunity to build against a pathogen. ... provide instantaneous protection against diseases caused by viruses and bacteria, ... being published in the Early Edition of the Proceedings ...
Cached Medicine News:Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 2Health News:The Flag Company, Inc. Releases 'Feel Good' Light Lenses to Help Counter Gloomy Economic Outlook 3Health News:Shopping for a Vacuum Cleaner? Know What You're Buying! Internet Site and Rating System Can Help 2Health News:Shopping for a Vacuum Cleaner? Know What You're Buying! Internet Site and Rating System Can Help 3Health News:CMPMedica Signs an Agreement With MAIDIS for e-prescribing Solutions in Abu Dhabi (UAE) 2Health News:CMPMedica Signs an Agreement With MAIDIS for e-prescribing Solutions in Abu Dhabi (UAE) 3Health News:Satellite Healthcare Researchers to Present at 29th Annual Dialysis Conference 2Health News:Satellite Healthcare Researchers to Present at 29th Annual Dialysis Conference 3Health News:CRN Responds to GAO Report on Dietary Supplements 2Health News:CRN Responds to GAO Report on Dietary Supplements 3Health News:Scripps research scientists engineer new type of vaccination that provides instant immunity 2Health News:Scripps research scientists engineer new type of vaccination that provides instant immunity 3
The Tag-It™ Cystic Fibrosis ASR reagents can be used by high complexity CLIA approved laboratories for detection of up to 70 mutations and 6 variants (polymorphisms) in the cystic fibrosis tran...
Paraffin Block Storage System...
The Modular Storage Drawers provide permanent storage and identification of up to 165 embedding rings or 250 cassettes per drawer....
Improving on the technology that the world has come to expect from the original SHUR/Mark® Cassette and Slide Labelers, SHUR/Mark® PLUS offers many added enhancements....
Medicine Products: